Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 145 participants.
Also called NCT06955104
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 145 participants
- Sponsor
- Registry
-
NCT06955104
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT06955104. Randomized; quadruple masking; primary purpose treatment. Start 2025-04-03 (actual); primary completion 2025-07-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia
- Condition
- Dyslipidemia
- Intervention (Drug)
- JW0108 + C2407
- Intervention (Drug)
- JW0108 + C2407 placebo
- Lead sponsor
- JW Pharmaceutical
Record details
- Record id
cardio:ct-nct06955104- Content hash
2b129dbaffbd89a3e10a4ea68e0d1ac7891b603bb4e2b5cc6525c2998a0a1903